Results 111 to 120 of about 683 (135)
Some of the next articles are maybe not open access.
Azilsartan medoxomil (Edarbi) the eighth ARB.
The Medical letter on drugs and therapeutics, 2011The angiotensin receptor blocker (ARB) azilsartan medoxomil (Edarbi-Takeda) was recently approved by the FDA for oral treatment of hypertension, either alone or combined with other drugs. It is the eighth ARB approved for this indication.
openaire +1 more source
International Journal of Polymeric Materials and Polymeric Biomaterials, 2021
Jyotsana Madan, , Kamal Dua
exaly
Jyotsana Madan, , Kamal Dua
exaly
DRUG UTILIZATION STUDY FOR AZILSARTAN MEDOXOMIL IN GERMANY
Journal of Hypertension, 2018B. Ehlken +4 more
openaire +1 more source

